IIT Kanpur Develops Artificial Heart to Deal with Acute Cardiac Problems: IIT Kanpur is ready with an artificial heart that would be of great help to people with acute cardiac problems. Abhay Karandikar, the director of IIT Kanpur, announced that the animal testing would start the next year.
December 2022 Current Affairs Quiz
More About This:
Now heart transplant will be easy. Artificial hearts can be implanted in serious patients. This artificial heart was created by cardiologists from across the nation and IIT Kanpur. Animal trials will begin in February or March. After success in the trial, transplantation can be done in humans in the next two years. Artificial heart is being developed to reduce the sufferings of the patients.
A team of 10 scientists and doctors has prepared this artificial heart. After the success of the trial on animals, heart transplantation in humans will begin within two years.
Significance Of This:
80 percent of the equipment and implants in India are imports. There are just 20% of the implants and equipment that are produced in India. Most of the implants and stents for heart patients are being imported.
Covid-19 taught us some hard lessons. Before Covid, ventilators were not made in India. To save the lives of corona-infected, Indian scientists and doctors prepared ventilators in just 90 days. In India, two businesses produce ventilators. While foreign ventilators cost between Rs 10 and Rs 12 lakh, Indian ventilators only cost Rs 2.5 lakh to produce.
About This Project:
The School of Medical Research and Technology (SMRT) of IIT Kanpur has launched the Hridyantra, a challenge-based programme to develop advanced artificial heart also called Left Ventricular Assist device (LVAD) for patients with end-stage heart failure in January 2022. The programme has been launched in collaboration with nation’s leading hospitals and will be steered by a team of innovators with relevant experience selected under the mentorship of a task force comprising industry experts. The project was seed-funded by Padma awardee Sudha Murthy and the Indian Council of Medical Research (ICMR).
